AbbVie Inc. (ABBV)
AbbVie Inc is an American multinational biopharmaceutical company based in North Chicago, Illinois. It was created in 2013 as a spin-off of Abbott Laboratories. AbbVie is focused on developing and marketing advanced therapies for severe and chronic conditions, emphasizing oncology, immunology, and virology.
Company Info
ISIN | US00287Y1091 |
---|---|
CUSIP | 00287Y109 |
Sector | Healthcare |
Industry | Drug Manufacturers—General |
Highlights
Market Cap | $314.19B |
---|---|
EPS | $2.72 |
PE Ratio | 65.39 |
PEG Ratio | 0.49 |
Revenue (TTM) | $54.32B |
Gross Profit (TTM) | $41.53B |
EBITDA (TTM) | $26.36B |
Year Range | $127.03 - $182.89 |
Target Price | $183.39 |
Short % | 0.81% |
Short Ratio | 2.75 |
Share Price Chart
Loading data...
Compare to other instruments
Popular comparisons: ABBV vs. ABT, ABBV vs. PFE, ABBV vs. JNJ, ABBV vs. MSFT, ABBV vs. SCHD, ABBV vs. PEP, ABBV vs. WMT, ABBV vs. ADI, ABBV vs. VOO, ABBV vs. EPD
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in AbbVie Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
AbbVie Inc. had a return of 16.28% year-to-date (YTD) and 20.42% in the last 12 months. Over the past 10 years, AbbVie Inc. had an annualized return of 17.59%, outperforming the S&P 500 benchmark which had an annualized return of 10.71%.
Period | Return | Benchmark |
---|---|---|
Year-To-Date | 16.28% | 7.96% |
1 month | 0.56% | 2.87% |
6 months | 18.23% | 15.63% |
1 year | 20.42% | 31.48% |
5 years (annualized) | 22.89% | 12.80% |
10 years (annualized) | 17.59% | 10.71% |
Monthly Returns Heatmap
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2024 | 7.10% | 7.09% | ||||||||||
2023 | -1.75% | 1.43% | -4.34% | 0.86% | 8.83% |
Risk-Adjusted Performance
Risk-Adjusted Performance Indicators
This table presents risk-adjusted performance metrics for AbbVie Inc. (ABBV) and compares them with a selected benchmark (^GSPC). These performance indicators assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Sharpe ratio | Sortino ratio | Omega ratio | Calmar ratio | Ulcer Index | |
---|---|---|---|---|---|
AbbVie Inc. | 1.04 | ||||
S&P 500 | 2.54 |
Dividends
Dividend History
AbbVie Inc. granted a 3.36% dividend yield in the last twelve months. The annual payout for that period amounted to $5.99 per share.
Period | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Dividend | $5.99 | $5.92 | $5.64 | $5.20 | $4.72 | $4.28 | $3.59 | $2.56 | $2.28 | $2.02 | $1.66 | $1.60 |
Dividend yield | 3.36% | 3.82% | 3.49% | 3.84% | 4.41% | 4.83% | 3.89% | 2.65% | 3.64% | 3.41% | 2.54% | 3.03% |
Monthly Dividends
The table displays the monthly dividend distributions for AbbVie Inc.. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2024 | $1.55 | $0.00 | ||||||||||
2023 | $1.48 | $0.00 | $0.00 | $1.48 | $0.00 | $0.00 | $1.48 | $0.00 | $0.00 | $1.48 | $0.00 | $0.00 |
2022 | $1.41 | $0.00 | $0.00 | $1.41 | $0.00 | $0.00 | $1.41 | $0.00 | $0.00 | $1.41 | $0.00 | $0.00 |
2021 | $1.30 | $0.00 | $0.00 | $1.30 | $0.00 | $0.00 | $1.30 | $0.00 | $0.00 | $1.30 | $0.00 | $0.00 |
2020 | $1.18 | $0.00 | $0.00 | $1.18 | $0.00 | $0.00 | $1.18 | $0.00 | $0.00 | $1.18 | $0.00 | $0.00 |
2019 | $1.07 | $0.00 | $0.00 | $1.07 | $0.00 | $0.00 | $1.07 | $0.00 | $0.00 | $1.07 | $0.00 | $0.00 |
2018 | $0.71 | $0.00 | $0.00 | $0.96 | $0.00 | $0.00 | $0.96 | $0.00 | $0.00 | $0.96 | $0.00 | $0.00 |
2017 | $0.64 | $0.00 | $0.00 | $0.64 | $0.00 | $0.00 | $0.64 | $0.00 | $0.00 | $0.64 | $0.00 | $0.00 |
2016 | $0.57 | $0.00 | $0.00 | $0.57 | $0.00 | $0.00 | $0.57 | $0.00 | $0.00 | $0.57 | $0.00 | $0.00 |
2015 | $0.49 | $0.00 | $0.00 | $0.51 | $0.00 | $0.00 | $0.51 | $0.00 | $0.00 | $0.51 | $0.00 | $0.00 |
2014 | $0.40 | $0.00 | $0.00 | $0.42 | $0.00 | $0.00 | $0.42 | $0.00 | $0.00 | $0.42 | $0.00 | $0.00 |
2013 | $0.40 | $0.00 | $0.00 | $0.40 | $0.00 | $0.00 | $0.40 | $0.00 | $0.00 | $0.40 | $0.00 | $0.00 |
Dividend Yield & Payout
Dividend Yield
Payout Ratio
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below displays the maximum drawdowns of the AbbVie Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the AbbVie Inc. was 45.09%, occurring on Aug 15, 2019. Recovery took 330 trading sessions.
The current AbbVie Inc. drawdown is 1.50%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
---|---|---|---|---|---|---|
-45.09% | Jan 29, 2018 | 390 | Aug 15, 2019 | 330 | Dec 4, 2020 | 720 |
-31.61% | Jul 29, 2015 | 61 | Oct 22, 2015 | 383 | May 2, 2017 | 444 |
-21.92% | Apr 11, 2022 | 120 | Sep 30, 2022 | 320 | Jan 10, 2024 | 440 |
-19.82% | Dec 8, 2014 | 43 | Feb 9, 2015 | 90 | Jun 18, 2015 | 133 |
-13.11% | Dec 19, 2013 | 25 | Jan 27, 2014 | 78 | May 19, 2014 | 103 |
Volatility
Volatility Chart
The current AbbVie Inc. volatility is 4.19%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Income Statement
TTM | 2023 | 2022 | 2021 | 2020 | 2019 | |
---|---|---|---|---|---|---|
Revenue | ||||||
Total Revenue | 54.32B | 54.32B | 58.05B | 56.20B | 45.80B | 33.27B |
Cost Of Revenue | 17.10B | 8.78B | 17.41B | 17.45B | 15.39B | 7.44B |
Gross Profit | 37.22B | 45.54B | 40.64B | 38.75B | 30.42B | 25.83B |
Operating Expenses | ||||||
Selling, General & Admin Expenses | 12.87B | 12.87B | 13.26B | 10.25B | 9.50B | 6.94B |
R&D Expenses | 7.67B | 7.03B | 6.51B | 7.08B | 6.56B | 6.41B |
Total Operating Expenses | 22.66B | 28.11B | 21.83B | 19.87B | 17.86B | 12.46B |
Income | ||||||
Income Before Tax | 6.25B | 6.25B | 13.48B | 12.99B | 3.40B | 8.43B |
Operating Income | 14.06B | 17.43B | 18.12B | 17.92B | 476.00M | 12.98B |
EBIT | 11.67B | 9.40B | 18.12B | 17.92B | 476.00M | 12.98B |
Earnings From Continuing Operations | 4.87B | 4.87B | 11.85B | 11.55B | 4.62B | 7.88B |
Net Income | 4.86B | 4.86B | 11.84B | 11.54B | 4.62B | 7.88B |
Income Tax Expense | 1.38B | 1.38B | 1.63B | 1.44B | -1.22B | 544.00M |
Interest Expense | 1.87B | 1.67B | 2.23B | 2.38B | 2.28B | 1.51B |
Other Non-Operating Income (Expenses) | -7.00B | -11.18B | -3.29B | -3.51B | 2.92B | -4.56B |
Extraordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Effect Of Accounting Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non Recurring | 430.00M | 0.00 | 697.00M | 962.00M | 1.20B | 385.00M |
Minority Interest | -10.00M | -10.00M | -9.00M | -7.00M | 6.00M | 21.00M |
Other Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |